RxDoctor Payments Data

Darshan Patel

Interventional Pain Medicine · Fuquay Varina, NCNPI 1871955674

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for interventional pain medicine clinicians in NC, where the typical reported total is $2,787.

$1,082in general payments, 2019–2025

Across 31 payments — averaging $34.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$248
  • Abbott$236
  • Nevro Corp.$129
  • Boston Scientific$129
  • SPR Therapeutics, Inc$77
  • Curonix LLC$47
  • plus $217 from 11 others

What the payments were for

  • Food & beverage$1,082100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,082 in reported general payments places this provider in the 20th percentile of 45 interventional pain medicine providers in North Carolina.

See all interventional pain medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$169,999
Medicare patients
171
Services billed
2,296

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine59$8,131
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen283$6,282
OxycontinOxycodone Hcl13$6,103
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl22$5,287
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen257$4,309
Gabapentin280$3,000
Pregabalin136$2,881
Oxycodone Hcl148$2,821
Diclofenac Sodium113$2,510
Baclofen171$2,068
Naloxone Hcl17$1,309
Tizanidine Hcl133$1,269
Duloxetine Hcl40$1,019
Acetaminophen-CodeineAcetaminophen With Codeine17$764
Celecoxib23$427

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Fuquay Varina

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →